PROCLAIM-CX-072: Monotherapy for Advanced Triple-Negative Breast Cancer With Skin Metastases in a Phase 1/2a Trial of the PD-L1 Probody Therapeutic CX-072

Sylvia Adams, Erika Hamilton, Patrick A. Ott, Daniel Cho, Kevin Kalinsky, Patricia LoRusso, Matthias Will, Vanessa Huels, Beverly Benson, Carmen Murias, Hendrik-Tobias Arkenau. Poster presented at the 41st Annual San Antonio Breast Cancer Symposium, San Antonio, Texas.